U.S. markets closed
  • S&P Futures

    3,368.00
    +16.00 (+0.48%)
     
  • Dow Futures

    27,835.00
    +171.00 (+0.62%)
     
  • Nasdaq Futures

    11,459.50
    +52.25 (+0.46%)
     
  • Russell 2000 Futures

    1,513.10
    +8.70 (+0.58%)
     
  • Crude Oil

    40.19
    -0.03 (-0.07%)
     
  • Gold

    1,896.00
    +0.50 (+0.03%)
     
  • Silver

    23.64
    +0.15 (+0.62%)
     
  • EUR/USD

    1.1740
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    0.6770
    +0.0320 (+4.96%)
     
  • Vix

    26.37
    +0.10 (+0.38%)
     
  • GBP/USD

    1.2935
    +0.0014 (+0.11%)
     
  • USD/JPY

    105.5060
    +0.0760 (+0.07%)
     
  • BTC-USD

    10,829.73
    +33.70 (+0.31%)
     
  • CMC Crypto 200

    232.83
    +11.44 (+5.17%)
     
  • FTSE 100

    5,866.10
    -31.40 (-0.53%)
     
  • Nikkei 225

    23,184.93
    -0.19 (-0.00%)
     

Global Mice Model Market to 2027: U. S. Market is Estimated at $351.4 Million, While China is Forecast to Grow at 9.7% CAGR

Research and Markets

Dublin, Sept. 16, 2020 (GLOBE NEWSWIRE) -- The "Mice Model - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Mice Model Market to Reach $2 Billion by 2027

Amid the COVID-19 crisis, the global market for Mice Model estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 6.3% over the analysis period 2020-2027. CRISPR/CAS9, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$697.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Microinjection segment is readjusted to a revised 5.7% CAGR for the next 7-year period.

The U. S. Market is Estimated at $351.4 Million, While China is Forecast to Grow at 9.7% CAGR

The Mice Model market in the U. S. is estimated at US$351.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$432.5 Million by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Embryonic Stem Cell Injection Segment to Record 5.9% CAGR

In the global Embryonic Stem Cell Injection segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$184.5 Million in the year 2020 will reach a projected size of US$266.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$269.6 Million by the year 2027, while Latin America will expand at a 7.1% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 397-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Charles River Laboratories International, Inc.

  • Envigo, Inc.

  • Genoway S. A.

  • Harbour Antibodies BV

  • Horizon Discovery Group PLC

  • inGenious Targeting Laboratory, Inc.

  • Janvier Labs

  • Laboratory Corporation of America Holdings (LabCorp)

  • Taconic Biosciences, Inc.

  • The Jackson Laboratory

  • Trans Genic, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession

  • Global Competitor Market Shares

  • Mice Model Competitor Market Share Scenario Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 43

For more information about this report visit https://www.researchandmarkets.com/r/76gsi8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900